SafeScript NSW: approval management enhancements now available
02 Apr 2024
This extends the approval management functionality introduced last year enabling prescribers to manage their applications for approval to prescribe medicines under the NSW Opioid Treatment Program (OTP) and psychostimulants (dexamfetamine, lisdexamfetamine and methylphenidate).
More than 50 per cent of all applications to prescribe medicines under the OTP and psychostimulants are submitted through SafeScript NSW, with some receiving immediate approval (where required criteria are met).
This has improved the overall application process by reducing the time it takes to make an application and waiting for approvals to be processed.
SafeScript NSW’s approval management functionality offers an efficient and centralised way for prescribers to:
- easily submit their applications online
- monitor application progress
- receive responses to their applications faster, with approvals issued immediately in some cases
- cancel or exit an existing approval if it is no longer required
For more information, including resources to optimise your experience using SafeScript NSW, download this fact sheet
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
Popular Posts
Recent Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy